Alpha 2.0
Login Register
» Authors » Chih-Hsun Tai

Chih-Hsun Tai

Explore the profile of Chih-Hsun Tai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 36
Followers 0
Related Specialties
General Medicine
Infectious Diseases
Top 10 Co-Authors
Chien-Chih Wu
Shih-Chi Ku
Fang-Ju Lin
Chi-Chuan Wang
Chi-Hao Shao
Jann-Tay Wang
Shu-Wen Lin
Wei-Ling Liu
Wang-Huei Sheng
Che-Hao Chang
Published In
J Formos Med Assoc
Infect Drug Resist
Ther Clin Risk Manag
Ther Adv Drug Saf
J Antimicrob Chemother
Affiliations
Soon will be listed here.
Recent Articles
1.
Navigating pharmacokinetic and pharmacodynamics challenges of β-lactam antibiotics in patients with low body weight: efficacy, toxicity, and dosage optimization
Tseng Y, Tai C, Chen G, Chen Y, Ku S, Pai T, et al.
Ther Adv Drug Saf . 2025 Feb; 16:20420986251320414. PMID: 39974281
Background: Patients with low body weight (LBW) often exhibit altered pharmacokinetics (PK) in renal clearance and total body water. These changes complicate β-lactam antibiotic dosing, potentially resulting in suboptimal efficacy...
2.
Impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance among major pathogens causing healthcare-associated infection
Chang H, Chang C, Tien K, Tai C, Lin L, Lee T, et al.
J Formos Med Assoc . 2023 Jul; 123(1):123-132. PMID: 37451958
Background: Coronavirus disease 2019 (COVID-19) has caused great impact on healthcare systems, including antibiotic usage and multi-drug resistant (MDR) bacterial infections at hospitals. We aim to investigate the trends of...
3.
Evaluation of the Negative Predictive Value of Methicillin-Resistant Nasal Swab Screening in the Medical Intensive Care Units and Its Effect on Antibiotic Duration
Tai C, Liu W, Pan S, Ku S, Lin F, Wu C
Infect Drug Resist . 2022 Mar; 15:1259-1266. PMID: 35355623
Background: In addition to active surveillance of methicillin-resistant (MRSA) carrier, MRSA nasal screening can be valuable for antibiotic de-escalation. This study aimed to assess the correlations between the MRSA nasal...
4.
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
Shao C, Tai C, Lin F, Wu C, Wang J, Wang C
J Formos Med Assoc . 2021 Feb; 121(1 Pt 1):117-125. PMID: 33637370
Background/purpose: To compare the risk of acute kidney injury (AKI) among patients receiving teicoplanin (TA) plus piperacillin/tazobactam (TZP) versus vancomycin (VAN) plus TZP. Methods: This was a retrospective cohort study...
5.
Nephrotoxicity of teicoplanin-based combination therapy: focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams
Tai C, Shao C, Wang C, Lin F, Wang J, Wu C
J Antimicrob Chemother . 2020 Nov; 76(2):499-506. PMID: 33152760
Background: The concurrent use of vancomycin and piperacillin/tazobactam increases the risk of acute kidney injury (AKI) compared with vancomycin use with other anti-pseudomonal β-lactams (OAPBs). Teicoplanin is a glycopeptide antibiotic...
6.
Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study
Wu C, Tai C, Liao W, Wang C, Kuo C, Lin S, et al.
Infect Drug Resist . 2019 Sep; 12:2531-2541. PMID: 31496765
Background: Augmented renal clearance (ARC) is common in critically ill patients and could result in subtherapeutic antibiotic concentration. However, data in the Asian population are still lacking. The aim of...
7.
Safety of high-dose daptomycin in patients with severe renal impairment
Tai C, Shao C, Chen C, Lin S, Wu C
Ther Clin Risk Manag . 2018 Mar; 14:493-499. PMID: 29559785
Background: Treatment options are limited for infections due to multidrug-resistant Gram-positive pathogens. Daptomycin is a lipopeptide antibiotic with concentration-dependent killing characteristic and dose-dependent post-antibiotic effect. To achieve optimized pharma-codynamic effect,...